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We identify a major control mechanism of
Listeria virulence based on antagonistic
regulation by environmental peptides.
Activity levels of the virulence regulator
PrfA depend on the net balance between
the rates of synthesis of the PrfA-
activating cofactor GSH from exogenous
peptide-derived cysteine and of direct,
promiscuous PrfA inhibition by non-
cysteine-containing peptides.
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To optimize fitness, pathogens selectively activate
their virulence program upon host entry. Here, we
report that the facultative intracellular bacterium Lis-
teria monocytogenes exploits exogenous oligopepti-
des, a ubiquitous organic N source, to sense the
environment and control the activity of its virulence
transcriptional activator, PrfA. Using a genetic screen
in adsorbent-treated (PrfA-inducing) medium, we
found that PrfA is functionally regulated by the bal-
ance between activating and inhibitory nutritional
peptides scavenged via the Opp transport system.
Activatingpeptidesprovideessential cysteineprecur-
sor for the PrfA-inducing cofactor glutathione (GSH).
Non-cysteine-containing peptides cause promiscu-
ous PrfA inhibition. Biophysical and co-crystallization
studies reveal that peptides inhibit PrfA through steric
blockade of the GSH binding site, a regulation mech-
anism directly linking bacterial virulence and meta-
bolism. L. monocytogenesmutant analysis in macro-
phages and our functional data support a model in
which changes in the balance of antagonistic Opp-
imported oligopeptides promote PrfA induction intra-
cellularly and PrfA repression outside the host.INTRODUCTION
Listeria monocytogenes, the causative agent of foodborne liste-
riosis, is a paradigmatic example of a pathogen exerting tight
control over its virulence genes (Freitag et al., 2009). This ubiqui-
tous gram-positive bacterium uses a set of nine virulence factors
to promote host cell invasion (InlA, InlB), phagosomal escape
(hly-encoded LLO, PlcA, and PlcB), rapid cytosolic replication
(Hpt), and cell-to-cell spread (ActA, InlC) (Hamon et al., 2006).
Their expression is activated during cell infection (Chatterjee
et al., 2006; Shetron-Rama et al., 2002) and depends on PrfA
(Mengaud et al., 1991), a transcription factor of the Crp/Fnr fam-Cell Re
This is an open access article undily (Scortti et al., 2007). PrfA is essential for pathogenesis (Chak-
raborty et al., 1992) but is equally important for preventing the
cost of unneeded virulence factors in the environmental reservoir
(Vasanthakrishnan et al., 2015).
PrfA regulation operates through control of (1) PrfA abundance,
exerted at both the transcriptional and translational levels and
involving positive autoregulation of the prfA gene, and (2) PrfA ac-
tivity, via cofactor-mediated allosteric shift between low- (‘‘Off’’)
and high- (‘‘On’’) activity states (reviewed in Scortti et al. [2007]).
The latter is thought to play a key role in the strong PrfA induction
observed during intracellular infection (Deshayes et al., 2012).
Single amino acid substitutions, called PrfA* mutations, lock
PrfA in ‘‘On’’ conformation with increased DNA-binding activity
(Eiting et al., 2005; Vega et al., 1998), causing constitutive activa-
tion of virulence genes to high, ‘‘infection-like’’ levels (Ripio et al.,
1997b; Shetron-Rama et al., 2003; Vega et al., 2004). Recently, a
genetic screen in macrophages found that the thiol-redox buffer
glutathione (GSH, g-L-Glutamyl-L-cysteinylglycine) (Loi et al.,
2015), endogenously produced by the listerial GshF enzyme
(Gopal et al., 2005), was required to promote PrfA activation (Re-
niere et al., 2015). Exogenous GSH had a similar PrfA-inducing
effect in vitro in syntheticmedium (Portman et al., 2017). Co-crys-
tallization studies showed that GSH binds in a large tunnel be-
tween PrfA’s N-terminal and C-terminal domains, priming PrfA
for productive interaction with the target DNA (Hall et al., 2016).
While GSH is required for full PrfA induction and intracellular pro-
liferation (Gopal et al., 2005; Reniere et al., 2015), how GSH-
dependent PrfA activity is regulated remains to be clarified.
A combination of environmental and endogenous cues
converge on PrfA to modulate virulence expression. These
include temperature via an RNA thermoswitch that controls
prfA translation (Johansson et al., 2002), stress signals via a
SigB-regulated prfA promoter (Nadon et al., 2002), a reducing
environment (Portman et al., 2017), and metabolic signals,
including carbon-source nutrition (Joseph et al., 2008; Mile-
nbachs et al., 1997; Ripio et al., 1997a) or amino acid availability
(Haber et al., 2017; Lobel et al., 2015; Xayarath et al., 2009)
through as yet not fully understood mechanisms. In addition to
the intracellular milieu and GSH, treating the growth medium
with activated charcoal also causes strong PrfA induction (Ripio
et al., 1996;Milohanic et al., 2003). This phenomenon is observedports 26, 1815–1827, February 12, 2019 ª 2019 The Authors. 1815
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Characterization of Tn Mutants
(A) Transposon insertions. In black, those selected for detailedanalysis.Coordinates from thestart of anORF.Promoters are ascharacterized inWurtzel et al. (2012).
(B) PrfA-dependent expression of wild-type P14 (WT) and opp and gshF Tnmutants using Phly-lux reporter (left) and actA transcription analysis by qRT-PCR (right,
data expressed as relative values to WT).
(C) Complementation of oppF589::Tn in BHI-Amb with oppF expressed from its own promoter (oppFPoppF) or opp operon promoter (oppFPopp), or with empty
vector.
(D) Growth curves of WT and oppF589::Tn complemented with oppF or empty vector.
(E) Opp– mutant exhibits wild-type (PrfA+) phenotype in CDM. Left: Phly-lux reporter normalized luminescence and growth curves (OD600) of WT, oppF::Tn, and
isogenic DgshF mutant in CDM. Right: phenotype of DgshF in BHI-Amb.
(F) Overexpression of gshF under the strong Pd promoter (de la Hoz et al., 2000) (gshFPd) in WT, oppF589::Tn (opp), and DgshF. gshF transcription by qRT-PCR in
BHI-Amb. Non-complemented bacteria contain an empty vector.
(G) gshF overexpression does not rescue the PrfA– phenotype of opp mutant in BHI-Amb. Phly-lux maximum normalized luminescence.
(legend continued on next page)
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in complexmedia, such as brain-heart infusion (BHI), where PrfA-
dependent expression is very weak at 37C. Adsorbent resins,
such as Amberlite XAD4, have the same effect, suggesting that
the mechanism involves the sequestration of PrfA inhibitory sub-
stances (Ermolaeva et al., 2004).
In this study, we performed a transposon screen to charac-
terize the molecular basis of the intriguing effect of adsorbents
on listerial virulence expression. We show that this effect
depends on a functional Opp oligopeptide transporter, which
allows L. monocytogenes to control PrfA-GSH regulation ac-
cording to the ‘‘peptide signature’’ of the bacterial habitat.
RESULTS
Genetic Screen for Amberlite XAD4 Non-activable
Mutants
A himar1 transposon (Tn) library was constructed in
L. monocytogenes P14-Phly-lux, a wild-type serovar 4b isolate
carrying a chromosomally integrated luxABCDE reporter under
the control of the PrfA-regulated hly promoter (Bron et al.,
2006). ‘‘Non-activable’’ (PrfA–) Tn mutants were selected in Am-
berlite XAD4-treated BHI (BHI-Amb) by exploiting the ability of
the PrfA-regulated organophosphate permease Hpt to confer
susceptibility to the antibiotic fosfomycin (Scortti et al., 2006)
(see STAR Methods). Apart from prfA and hpt, two other loci
were redundantly targeted upon screening z500 fosfomycin
resistant mutants (Figure 1A): gshF encoding the listerial GSH
synthase, the inactivation of which was previously shown to
result in reduced PrfA-dependent expression (Reniere et al.,
2015); and oppDF encoding the ATPase subunits of the Opp oli-
gopeptide transport system (Borezee et al., 2000).
The oppD/F::Tn mutants exhibited similar phenotype to the
gshF::Tn mutants, characterized by a pleiotropic PrfA-regu-
lated gene activation defect in BHI-Amb as determined using
reporter gene tests (Figures S1A–S1C) and promoter activa-
tion/gene expression analyses (Figure 1B). Knockout muta-
genesis of oppD and oppF recapitulated the PrfA– phenotype
(Figure S1D). Complementation of one of the Tn mutants
selected for further characterization (oppF589; Figure 1A)
rescued the parental wild-type PrfA+ phenotype (Figure 1C).
This identified the opp locus as potentially involved in PrfA
regulation.
Link between Opp Peptide Transport and PrfA
Regulation
oppF::Tn (all opp Tn mutants) showed impaired growth in BHI
and acquired resistance to bialaphos, a toxic tripeptide that
bacteria take up through Opp permeases (Borezee et al.,
2000). Complementation rescued both phenotypes (Figures
1D and S1E), confirming that the oppF mutation disabled
Opp function. For simplicity, oppF::Tn is henceforth designated(H) Rescue of opp mutant by exogenous GSH (1 mM) in BHI-Amb. Note that 1
concentration of 8 mM; data not shown). This may reflect that, in BHI-Amb, exog
threshold for normal PrfA activity in the absence of an endogenous (GshF-derive
Data in (B) and (C) left, (D), and (E) are mean ±SEM from a representative experime
SEMof three independent experiments, each in tripiclate. Significant p values are
See also Figures S1 and S2.as opp (or Opp–) mutant. As expected, opp bacteria showed
wild-type growth in chemically defined medium (CDM) only
containing free amino acids as proteinogenic N (Figure 1E,
left). Notably, in CDM, the opp mutant also exhibited a PrfA+
phenotype equivalent to that of the wild-type parent in BHI-
Amb (Figure 1E), whereas Amberlite XAD4 has no effect on
wild-type L. monocytogenes (Figure S2). These data implied
that the adsorbent removes some critical Opp-transported
BHI component(s), presumably of peptide nature, which af-
fect(s) PrfA regulation.
Since growth in CDM rescued the opp mutant, and a DgshF
mutant constructed in P14 exhibited PrfA– phenotype in both
CDM and BHI-Amb (Figure 1E), gshF is clearly downstream of
opp and/or dominant in the PrfA regulation pathway. Tran-
scription analysis excluded that the PrfA– phenotype of the
opp mutant in BHI-Amb was due to reduced gshF expression
(Figure 1F). In addition, overexpression of gshF under the con-
trol of a strong promoter (Pd; de la Hoz et al., 2000) (Figure 1F)
did not reverse the PrfA– phenotype of opp bacteria in BHI-
Amb, while it successfully complemented the DgshF mutation
(Figure 1G). However, exogenous addition of 1 mM GSH fully
restored the parental PrfA+ phenotype in the opp mutant (Fig-
ure 1H). Thus, when Opp function is affected, the limiting fac-
tor for PrfA activation does not seem to be the levels of gshF
expression but, critically, the amounts of its biosynthetic prod-
uct, GSH. Overall, these results suggested that an Opp-trans-
ported BHI component controls the synthesis or availability of
endogenous GSH for PrfA activation.
Cysteine as Part of an Oligopeptide Mediates Opp-
Dependent PrfA Upregulation
Adding all CDM amino acids to BHI-Amb rescued the wild-type
PrfA+ (and growth) phenotype in the oppmutant (Figures 2A and
2B). We traced the effect to L-cysteine (Cys) (Figure 2C).
Although Cys is an essential amino acid for L. monocytogenes
(Tsai and Hodgson, 2003; Figure S3A), dose-dependent PrfA in-
duction was observed in CDM for both wild-type and opp bacte-
ria once the minimum concentration for eugonic growth
(z0.2 mM) had been reached (Figure S3B). Since adding Cys
to BHI-Amb recapitulated the functional complementation by
GSH, and Cys is an essential rate-limiting precursor for GSH
biosynthesis (Loi et al., 2015; Lu, 2009), we reasoned that the
PrfA– phenotype of the opp mutant could result from an inability
to incorporate Cys in oligopeptide form. Confirming this, like
free Cys, a Cys-containing tetrapeptide (RGDC) promoted
growth and PrfA-dependent expression in wild-type
L. monocytogenes, but not in the opp mutant (Figures 2D,
S3C, and S3D). That the DgshF mutant was not rescued in
(Cys-replete) CDM (Figure 1E, left) rules out that Cys acts as a
direct PrfA activator. Thus, the PrfA– phenotype of Opp–
L. monocytogenes in BHI-Amb is most likely explained by anmM exogenous GSH did not revert the PrfA– phenotype in DgshF (even at a
enous GSH is insufficient for the intrabacterial GSH concentration reaching a
d; Gopal et al., 2005) GSH pool.
nt of at least three biological replicates; in (B) and (C) right, and (F)–(H), means ±
indicated (B, right; C, right; and F, one-way ANOVA; G and H, two-way ANOVA).
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Figure 2. PrfA Regulation by Cys- and Non-Cys-Containing Peptides
(A) Rescue of oppmutant by supplementation of BHI-Amb with CDM amino acids (same final concentration). Expression level of WT shown as reference. Mean ±
SEM of two triplicate experiments.
(B) Representative growth curves from (A). Supplementation of BHI-Amb (and BHI, not shown) with CDM amino acids restores WT growth in opp mutant.
(C) Rescue of opp mutant by L-cysteine. BHI-Amb was supplemented with the same concentration of CDM amino acids added in a mix or individually.
(D) Opp-dependent PrfA induction by Cys-containing oligopeptide. Phly-lux expression (left) and growth (right) in CDM (without Cys) supplemented with 0.8 mM
Cys or 0.32 mM RGDC peptide. Data in (C) and (D) are means ± SEM of a representative triplicate experiment.
(E) Opp-dependent GSH synthesis. Total GSH (GSHt) was determined in wild-type and opp L. monocytogenes grown in CDM containing 0.2 mM Cys and
supplemented with 1 mM RGDC peptide or free Cys. DgshF, negative control. GSHt expressed as mM per 1010 CFU. Mean ± SEM of three experiments in
duplicate.
(F–H) Opp-dependent PrfA inhibition by non-Cys peptides in CDM. Means ± SEM of three triplicate experiments. Statistically significant p values are indicated
(two-way ANOVA).
(F) Phly-lux expression in WT, oppmutant and complemented oppmutant (compl.) in response to 1 mM synthetic tetrapeptides containing or not containing Cys.
Control, no peptide. opp mutant carries empty vector.
(G) Effect of several 5- to 8-mer non-Cys synthetic peptides on WT and opp mutant.
(H) Effect of several tripeptides, Leu dipeptide, and 1 mM free L-Leu. Note the partial Opp-independent inhibition by LL, suggesting alternate import by other
(dipeptide) transporter(s) (Monnet, 2003; Wouters et al., 2005). Asterisk indicates p = 0.009 relative to opp mutant in control conditions.
See also Figures S3 and S4.inability to incorporate Cys-containing peptides for endogenous
(GshF-mediated) biosynthesis of the PrfA-activating cofactor
GSH in Cys-limiting conditions. Total GSH determinations in
bacteria grown in CDM with limiting (0.2 mM) Cys (Figure S3AB)
confirmed that both RDGC peptide and free Cys were required1818 Cell Reports 26, 1815–1827, February 12, 2019for synthesis of the PrfA cofactor, the former in an Opp-depen-
dent manner (Figure 2E). In addition to an essential GSH building
block, the amino acid Cys could act as a thiol donor (Ohtsu et al.,
2010), potentially contributing to a reducing environment impor-
tant for PrfA activation (Portman et al., 2017).
PrfA Repression by Non-Cys-Containing Peptides
We compared the effect of Cys-containing synthetic oligopepti-
des (Cys-peptides) transported by Opp (RGDC, EVFC, TKPC;
Figure S4) and versions thereof with Cys replaced by another
residue (RGDL, EVFL, TKPR). Regular CDM (0.8 mM Cys) was
used to ensure normal growth in the absence of Cys-peptides.
While 1 mM Cys-peptide did not alter (or increased) Phly-lux
expression, equivalent amounts of the corresponding non-Cys-
peptides caused significant Opp-dependent PrfA downregula-
tion (69%–74%, p < 0.001) (Figure 2F). TKPR is aka tuftsin, a
mamalian immunomodulatory tetrapeptide from the Fc domain
of immunoglobulin G (IgG) (Wu et al., 2012). A listerial derived
octapeptide, ASSLLLVG (putative peptide pheromone pPplA;
Xayarath et al., 2015), also caused comparable Opp-dependent
repression (88%) (Figure 2G). Of three known > 5-mer listerial
Opp substrates (Borezee et al., 2000; Whiteley et al., 2017),
two were significantly inhibitory (KLLLLK 96%, SQNPYPIV
59%, RKDVY no effect) (Figure 2G). Tripeptides also caused
Opp-dependent PrfA downregulation, as illustrated with EVF
(truncated derivative of EVFC/L, 81%), ALV (90%) or LLL
(3-mer peptide of Leu used to replace the Cys residue in two
of the above repressing tetrapeptides, 87%) (Figure 2H). A Leu
dipeptide caused the same strong inhibition as LLL (93%). How-
ever, equivalent molar amounts of free Leu were not inhibitory
(p > 0.999), indicating that PrfA repression is specifically linked
to the peptide form of the amino acid (Figure 2H). Other tested
dipeptides showed different degrees of PrfA repressing activity
(AF 93%, AL 75%, FV 45%, AG 0%).
Overall, our data show that in PrfA-permissive (Cys-replete)
conditions, many tested non-Cys peptides, including host- or
bacteria-derived peptides, inhibit PrfA.
Balance of Inducing and Inhibitory Peptides Controls
PrfA
Next, we analyzed the combined effect of PrfA-inducing and
inhibitory peptides. In RGDC/RGDL titrations, the Cys-peptide
was clearly dominant at all tested RGDL concentrations (Fig-
ure 3A), while maximal inhibition was observed when RGDC
was omitted (Figure 3B). In contrast, RGDC/LLL titrations re-
sulted in a linear repression response as the LLL concentration
increased (Figure 3C). These data show that different inhibitory
peptides differ in the ability to counteract the PrfA-stimulating
effect of Cys-peptides.
We also tested the effect of increasing RGDC concentrations
against a fixed ‘‘non-saturating’’ amount (0.25 mM) of the
strongly repressing Leu di- and tripeptides. Even at the low
concentration of 80 mM, the RGDC peptide completely
cancelled LL/LLL-mediated repression (Figures 3D and 3E).
Comparatively larger amounts of free Cys (6.4 mM) were
required to achieve the same effect (Figure 3F). When 320 mM
RGDC or 1 mM GSH were added after several hours of growth
in CDM containing limiting Cys (0.1 mM, sufficient to promote
growth but not PrfA-dependent expression), the Cys-peptide
was again more effective in countering LL/LLL-mediated
repression (Figures 3G and 3H). Thus, peptide-mediated PrfA
inhibition is more efficiently reversed by Cys-peptides than
free Cys or, indeed, exogenous GSH, underscoring the impor-
tance of Opp in PrfA regulation.Interestingly, with no differences in the bacterial growth
dynamics, a protracted repression was observed with LLL, but
not LL, until RGDC, Cys, or GSH exhibited their PrfA-stimulatory
effect (Figures 3D–3H). This is likely due to release of repressing
LL dipeptide intermediate during the metabolic breakdown of
LLL into non-repressing free Leu (Figure 2H).
Collectively, our results indicate that PrfA induction levels
depend on the balance of inhibitory and inducing oligopeptide
inputs from the medium, and that the stoichiometry and dy-
namics of this balance is critically affected by the composition
of the peptide mixture.
Opp Is Required for Early PrfA Induction within Host
Cells
Weexaminedwhether theOpp transport systemplays any role in
intracellular PrfA activation in infected J774 mouse macro-
phages. An oppDF deletion mutant was used to avoid potential
problems of transposon instability in the harsher intracellular
conditions. P14DoppDF exhibited PrfA and oligopeptide trans-
port phenotypes indistinguishable from those of the Tn mutants
(Figures S1F and S1G). Intracellular PrfA induction, as monitored
by actA transcription, was significantly reduced (z60%) in
DoppDF at t = 2 h and 4 h compared to wild-type (Figure 4A).
The induction defect was similar (t = 2 h, p = 0.53), or marginally
less pronounced (t = 4 h, p = 0.04), to that of control PrfA activa-
tion-deficient DgshF (Reniere et al., 2015). However, no differ-
ences were observed at later stages of intracellular infection
(t = 7 h) (Figure 4A). These results indicate that Opp is required
for early intracellular PrfA activation, presumably by permitting
the incorporation of Cys in peptide form according to our
in vitro functional data. To further document this, macrophages
were deprived of Cys and then pre-treated with the GSH-
depleting drug buthionine sulfoximine (BSO) (Reniere et al.,
2015; Rouzer et al., 1981) to minimize the potential input of
host cell-derived free Cys and GSH pools. In these conditions,
DoppDF exhibited the same actA induction defect at t = 4, while
no significant changes were observed for the wild-type (Fig-
ure 4B), consistent with the PrfA activation deficit being attribut-
able to defective import of Cys-containing peptides.
Nutritional versus PrfA Regulatory Roles of Opp in
Virulence
Experiments with DoppDF show that listerial Opp is required for
efficient growth in macrophages (Figure 4C) (Borezee et al.,
2000) and full virulence in a mouse model of systemic infection
(Figure S5). This could result from either defective activation of
the PrfA virulence regulon (Figure 4A), or defective growth due
to impaired utilization of host-derived peptides (Figures 1D, 2B,
and2D, right). Todissect this,weanalyzed the intracellularpheno-
type of DoppDFwith PrfA regulation bypassed using a prfA*G145S
allele (Figure 4D). prfA*G145S bacteria overexpress the PrfA regu-
lon without the need of adding adsorbents to the BHI (Ermolaeva
et al., 2004;Ripio et al., 1996, 1997b), independently orgshF/GSH
(Reniere et al., 2015), and are largely unsusceptible to peptide-
mediated regulation (Figure S6). Growth of prfA*DoppDFwas still
strongly affected (Figure 4E), indicating that peptides are used as
the main amino acid source intracellularly, consistent with previ-
ous data using auxotrophic mutants (Marquis et al., 1993).Cell Reports 26, 1815–1827, February 12, 2019 1819
Figure 3. Antagonistic Control by PrfA-Inducing and PrfA-Repressing Peptides
(A–C) Phly-lux maximum normalized luminescence of WT in CDM containing mixtures of inducing RGDC peptide and cognate repressing RGDL peptide (A), same
experiment without RGDC peptide (B), or RGDL peptide replaced by strongly repressing LLL peptide (C). Final peptide concentration, 1 mM; control, no peptide.
Mean ± SEM of three triplicate experiments. p values relative to first column are shown (one-way ANOVA).
(D–H) Reversal of Leu peptide-mediated PrfA repression by Cys-peptide (D, E, G, H), free Cys (F), or GSH (G, H). Experiments performed in CDM containing
limiting Cys (0.1 mM). Normalized luminescence of WT along the bacterial growth curve (average OD600 values in gray). Gray double arrows and downward-
pointing arrows indicate the expression delay caused by LLL, but not LL, peptide, and time of addition of RGDC peptide or GSH, respectively. Note in (D)–(H) the
gradual decline of the expression signal until the end of the exponential growth phase, likely reflecting progressive exhaustion of the PrfA-stimulating input (and,
eventually, accumulation of bacteria-derived PrfA repressor products in the medium (Ermolaeva et al., 2004). Data in (D)–(H) are means ± SEM of a representative
triplicate experiment.To assess the impact of Opp-dependent PrfA activation, we
compared the intracellular dynamics of DoppDF expressing
wild-type PrfA (PrfAWT), which necessitates activation to pro-
mote infection (Deshayes et al., 2012), or constitutively acti-
vated PrfA*. Because the strong nutritionally related prolifera-
tion defect caused by the Opp– mutation could mask PrfA-
related effects (see DoppDF bacteria in Figures 4C and 4E),
we used a competition assay to enhance discrimination. No
differences in competitive ability were observed between
PrfAWT- and PrfA*-expressing Opp-proficient bacteria, con-
firming that the levels of virulence gene activation are in
both cases similar (Figure 4F, left). In contrast, when Opp
was absent, PrfAWT bacteria (requiring Opp for efficient PrfA
activation; Figure 4A) were outcompeted by those with consti-
tutively activated PrfA* (Figure 4F, right). Overall, these data
identify Opp as an important listerial virulence determinant1820 Cell Reports 26, 1815–1827, February 12, 2019with key dual roles in N nutrition and PrfA activation within
host cells.
Peptide-Mediated Regulation Is Due to Changes in PrfA
Activity
To explore the mechanism behind PrfA regulation by peptides,
we examined the correlation between PrfA-dependent expres-
sion and PrfA protein abundance in activating and inhibiting
conditions. Since PrfA positively autoregulates its own gene
(Mengaud et al., 1991) (Figure 5A), variations in PrfA activity
also affect PrfA concentration (Vega et al., 1998). This problem
was circumvented by disrupting the transcriptional positive
feedback loop (strain P14prfAmc; Figure 5A). Even without PrfA
autoregulation, P14prfAmc showed the expected PrfA induction
patterns under strongly upregulating (CDM medium supple-
mented with extra Cys, Cys-peptide or GSH) or downregulating
Figure 4. Opp-Dependent PrfA Activation
and Replication within Host Cells
(A) actA transcription analysis by qRT-PCR of WT,
DoppDF, and (control) DgshF and DprfA de-
rivatives in J774A.1 mouse macrophages at t = 2,
4, and 7 h after infection.
(B) actA transcription analysis of WT and DoppDF
mutant in J774A.1 cells treated with the GSH-
depleting drug buthionine sulfoximine (BSO) at t =
4 h post-infection. Prior to infection, cells were
incubated in normal (–) or Cys-free medium fol-
lowed by BSO treatment (+).
(C) Intracellular replication of WT and DoppDF in
J774A.1 cells. Data are expressed as the normal-
ized intracellular growth coefficient (IGC; see STAR
Methods).
(D) actA transcription analysis of
L. monocytogenes prfA*G145S and prfA*DoppDF in
J774A.1 cells.
(E) Same as in (C) using bacteria with prfA* allele.
(F) Competition assay in J774A.1 macrophages
between L. monocytogenes P14 with wild-type
prfA allele (WT, DoppDF) and constitutively
activated prfA* allele (prfA*, prfA*DoppDF). Left:
comparison in Opp+ background (Opp-depen-
dent PrfA activation enabled). Right: comparison
in Opp– background (Opp-dependent PrfA
activation disabled). The bacteria used in
these experiments do not contain the luxABCDE
reporter. C.I., competitive index; values > 1
indicate competitive advantage for prfA*
bacteria.
Data are means ± SEM of at least two (A, B, D), three (C and E), or four (F) triplicate experiments. Relevant statistical comparisons are indicated. Two-way
ANOVA except one-way ANOVA in (D) and one-sample Student’s t test (hypothetical value of 1, two-tails) in (F). See also Figures S5 and S6.(addition of repressor peptide, growth in BHI) conditions (Fig-
ure 5B). Despite the widely different expression levels, no
concomitant changes in PrfA abundance were observed by
western immunoblotting (Figure 5C). Thus, PrfA regulation by
peptides is primarily exerted via control of PrfA protein activity,
not prfA gene expression.
Mechanism of Peptide-Mediated PrfA Inhibition
While the effect of Cys/Cys-peptides is explained by their essen-
tial role in the synthesis of the PrfA cofactor GSH, different mech-
anismsmay underlie peptide-mediated inhibition of PrfA activity.
We tested the simplest scenario, i.e., direct binding to PrfA.
Weak, albeit reproducible, increases in the melting temperature
(Tm) of purified PrfA, indicative of potential ligand-mediated pro-
tein stabilization, were observed for the strongly repressing LL
and LLL peptides in thermal shift assays (Renaud et al., 2016)
(Figures S7A and S7B). Isothermal titration calorimetry (ITC)
assays (Renaud et al., 2016) demonstrated that both peptides
have high affinity for PrfA (Kd z25 mM), while no binding was
detected for the non-inhibitory free Leu (Figure S7C). Biolayer
interferometry assays (Citartan et al., 2013) using a biotinylated
oligonucleotide containing the PrfA box of the PplcA/Phly pro-
moters demonstrated that the Leu peptides, but not free Leu,
strongly inhibit PrfA-DNA binding (Figure 6).
Structural evidence for the inhibitorymechanismwas obtained
through co-crystallization of PrfA with the LL dipeptide. The
asymmetric unit of the PrfA-LL complex determined at 2.7 A˚resolution contained a biological dimer identical to the previously
solved PrfAWT structure (Eiting et al., 2005) (Figure 7A, top). Dif-
ference Fourier and Polder electron density maps confirmed the
binding of the LL peptide to monomer A only (Figures S7D–S7F;
Table S1), as recently seen with synthetic PrfA inhibitors based
on ring-fused 2-pyridones (Good et al., 2016). LL is positioned
within the interdomain tunnel through hydrogen bonds with the
peptide backbone (Figures 7A and 7B). This tunnel was recently
identified as the binding site for the GSH cofactor (Hall et al.,
2016) (Figure 7A, bottom) and the ring-fused 2-pyridone inhibi-
tory ligands (Good et al., 2016; Kule´n et al., 2018). In the
PrfA-GSH complex, the backbone torsion angles of the GSH
tripeptide are in an extended b strand conformation leading
to five main-chain contacts with strands b5 and the turn con-
necting to b6 (Hall et al., 2016). Combined, these interactions
result in the partial collapse of the interdomain tunnel and
the positioning of aE from PrfA’s helix-turn-helix (HTH) motif
for productive DNA binding (Eiting et al., 2005; Hall et al., 2016)
(Figure 7A). Interestingly, the LL peptide is also in an extended
conformation and establishes two of the five main-chain con-
tacts made by GSH to b5 (residues Met58–Lys64) (Figure 7B).
Despite this and the fact that the side chain of Leu2 occupies
the same hydrophobic pocket as the thiol group of the GSH
molecule (Hall et al., 2016), wedged between the aromatic
residues Phe67 and Tyr126, the position of Leu1 is unique and
prevents the collapse of the tunnel needed for PrfA activation.
In particular, the 5 A˚ movement of Tyr154 involved in the intricateCell Reports 26, 1815–1827, February 12, 2019 1821
Figure 5. Peptide Regulatory Effects Are Due
to Changes in PrfA Activity
(A) Positive transcriptional autoregulation of PrfA.
Disruption of the PrfA-dependent plcA-prfA mes-
sage that drives the autoamplification loop (Men-
gaud et al., 1991) by insertional mutagenesis of the
plcA gene (strain P14prfAmc). In these conditions,
PrfA protein amounts only depend on the expres-
sion/translation levels of the non-PrfA-regulated
monocistronic prfA message (reviewed in Scortti
et al. [2007]). Relevant transcripts are shown; the
black square is the plcA PrfA-box (shared with the
divergently transcribed hly gene, which is not
shown).
(B) Phly-lux maximum normalized luminescence of
L. monocytogenes P14 (WT control) and P14prfAmc
derivative in conditions leading to different levels of
PrfA induction. Mean ± SEM of three triplicate
experiments. Relevant p values are indicated (one-
way ANOVA).
(C) PrfA western blot of L. monocytogenes cell
extracts obtained in (B). Left: representative
immunoblot,z2-3 mg of total protein in each lane.
Right: PrfA quantification from densitometric
scannings of the blots. Mean ± SEM of pooled
cultures from experiments in (B). Values for
P14prfAmc are not significantly different (one-way
ANOVA). Note the 15-fold greater PrfA protein
amount in wild-type L. monocytogenes compared
to P14prfAmc due to the functionality of PrfA’s
positive autoregulation.network of water-mediated hydrogen bonds connecting the
glycine of GSH with Ser177 in the HTH motif (Hall et al., 2016)
is sterically hindered by the Leu1 side chain (Figure 7C). Since,
in contrast to the LL peptide, GSH has weak affinity for PrfA
(Kd z4 mM, Reniere et al., 2015; undetectable by ITC), our
data suggest that the mechanism of peptide-mediated PrfA inhi-
bition involves, at least for some peptides, competitive occu-
pancy of the GSH binding site.
DISCUSSION
Virulence factors are essential for pathogenesis but a fitness
burden in non-infection conditions (Vasanthakrishnan et al.,
2015). Pathogens manage this dichotomy through virulence
gene regulators, but how they sense the transition into a pro-
pitious host habitat remains less well characterized. In this
study, we report an environmental regulation mechanism by
which L. monocytogenes controls the activity of its master
virulence switch, PrfA, through the balance of antagonistic ef-
fects of inducing and inhibitory peptides scavenged from the
medium. Our findings uncover a hitherto undescribed mecha-
nism of direct regulation of a bacterial transcription factor via
the oligopeptide composition of the habitat.
Inducing peptides provide Cys residue, which we show is
essential for PrfA activation through its key role as rate-limiting
GSH precursor (Loi et al., 2015; Lu, 2009). Our results show
that PrfA is regulated by the levels of Cys/Cys-peptides in the
medium, thus effectively linking the PrfA-GSH system to the
environmental conditions. The observed dissociation between
the nutritional role of Cys/Cys-peptides and virulence gene acti-1822 Cell Reports 26, 1815–1827, February 12, 2019vation (Figure S3) is consistent with Cys/Cys-peptides acting as
bona fide PrfA regulatory signals.
PrfA activation by Cys/Cys-peptides is antagonized by oligo-
peptides lacking Cys. Based on our data, an abundance of inhib-
itory peptides explains the weak PrfA-dependent expression
levels typically observed in BHI and other complex media (Ripio
et al., 1996, 1997b). Although not a requirement, Leu residues
were present in strongly repressing peptides. This was also
recently noted by Portman et al. (2017), who independently
observed that peptides in the listerial growth medium generally
inhibited PrfA. These authors attributed the effect of Leu-
containing peptides to inhibition of CodY-mediated prfA gene
activation (Lobel et al., 2015) in response to either increasing
concentrations of branched-chain amino acids (BCAAs) or strin-
gent response dampening upon addition of peptides (Portman
et al., 2017). However, our data show that free Leu does not
inhibit PrfA (Figure 2H), while the relatively elevated amounts of
BCAAs and other amino acids in CDM (in the mM range) are un-
likely to trigger a starvation response. Moreover, our experi-
ments with the P14prfAmc construct (Figure 5A), which includes
the regulatory region targeted by CodY (Lobel et al., 2015), show
that the effects of peptides are not due to changes in prfA
expression but in PrfA protein activity (Figures 5B and 5C). This
leaves two possible explanations for the repression mechanism:
(1) inhibition via unknown interposed factors or (2) direct interac-
tion with PrfA.
We documented the latter through biophysical studies and
co-crystallization of PrfA with inhibitory Leu dipeptide, which
located the ligand to the GSH binding site in PrfA’s interdo-
main tunnel. Strikingly, L-leucylleucine adopts the same
Figure 6. Peptide-Mediated Inhibition of PrfA-DNA Binding
Effect of inhibitory Leu peptides and free Leu on PrfA binding to the PplcA/hly
PrfA box measured by biolayer interferometry. Top: data for PrfAWT. showing
strong PrfA-DNA binding inhibition by the LL and LLL peptides but not free
Leu. Bottom: data for constitutively activated PrfA* showing unsusceptibility to
inhibition (consistent with functional data in Figure S6). Graphs represent the
binding signal plotted against PrfA concentration. Mean ± SEM of at least two
experiments. Relevant statistical comparisons are indicated (one-way
ANOVA). See also Figures S6 and S7.extended conformation and position as the g-glutamylcystei-
nylglycine tripeptide (Hall et al., 2016), making similar main-
chain contacts with PrfA residues (Figure 7B). This is reminis-
cent of the sequence-independent binding mechanism of the
OppA/AppA/DppA receptor proteins of ABC oligopeptide
transport systems (Monnet, 2003). The peptide is similarly
buried in a cavity between two large protein lobes (Figure 7A),
anchored via electrostatic contacts with the invariant a-linked
peptide backbone while large water-filled pockets easily
accommodate diverse side chains, imposing little binding
specificity (Berntsson et al., 2009; Levdikov et al., 2005). The
LL/LLL peptides bind to PrfA with mM affinity comparable to
that of the ligands accepted by OppA-type peptide-binding
proteins (Li et al., 2015). The PrfA interdomain tunnel is
spacious enough to accommodate four/six-mer peptides or
longer if overhanging outside PrfA. A surface lined with abun-
dant hydrophobic amino acids and also polar groups affords
flexible side-chain docking potential, consistent with the ability
of peptides of different polarity and composition to cause PrfA
inhibition.Our data provide a working model where the unique set of
conformational changes specifically triggered by GSH is hin-
dered by non-specific blockade of PrfA’s GSH binding site by
peptides. While activation requires occupancy of the two GSH
sites of the PrfA dimer (Hall et al., 2016), non-specific peptide
binding to only onemonomer (Figure 7A) suffices to alter the cor-
rect symmetry of the two HTH motifs, preventing DNA-binding
and virulence gene expression. Further work remains to fully
characterize the mechanism and dynamics of promiscuous inhi-
bition of PrfA by imported peptides and intermediate breakdown
products during their metabolic processing (Figure S8).
Free amino acids are foundat lowconcentrations in soil (z0.01
to0.15mM),whereasoligopeptides are themainorganicNsource
for microbial growth in the environment (Broughton et al., 2015;
Farrell et al., 2013). Because Cys is considerably less abundant
in proteins compared to other amino acids, soil oligopeptides
could be critical, together with other PrfA-repressing environ-
mental signals (temperature% 30C, plant-derived b-glucosides
and other phosphotransferase system (PTS)-transported sugars;
de las Heras et al., 2011) in preventing wasteful production of
virulence factors outside the host (FigureS8). How then to explain
the strong PrfA induction in the peptide-rich cytosol? Interest-
ingly, the Cys content is significantly higher in mammalian pro-
teins (2.3%) than in bacterial or plant proteins (0.5%–1%) (Miseta
and Csutora, 2000), which are the main source of organic N in
natural ecosystems. These differences may be sufficient to shift
the balance of inducing/inhibitory effects of peptides toward
PrfA upregulation. Specific cysteine-rich proteins from the host
may provide a unique source of PrfA-activating peptides. An
example is the Cys-rich miniproteins, which include the chemo-
kines and defensins, secreted by phagocytes or present in cells
typically targeted by L. monocytogenes, such as macrophages,
dendritic cells, and epithelial cells (Lavergne et al., 2012). Adding
a layer of complexity, mammalian immunomodulatory peptides
may also also cause PrfA inhibition, as illustrated here with the
IgG-derived prophagocytic tetrapeptide tuftsin (TKPR) (Wu
et al., 2012) (Figure 2F), potentially contributing to virulence
fine-tuning during infection. Finally, self-produced and other
microbially derived peptides, exemplified by the PplA peptide
(ASSLLLVG, Figure 2G), may allow coordinating PrfA regulation
according to population density or microbiome conditions
(Figure S8).
Based on our in vitro functional data, the significantly reduced
actA induction in Opp– L. monocytogenes within macrophages
at early/mid time points of infection –comparable to that of the
DgshF mutant– suggests that Cys-peptides contribute to PrfA-
GSH system upregulation upon host cell invasion. Although
GSH is present intracellularly at high concentrations (1–10 mM)
(Banerjee, 2012; Lu, 2009), the GshF dependence of PrfA induc-
tion within macrophages (Reniere et al., 2015) (Figure 4A) argues
against listerial uptake of host-cell GSH having a main contribu-
tion. Free Cys is also unlikely to be sufficient to promote PrfA
activation because its intracellular concentrations are normally
kept at low (mM), limiting steady-state levels due to its cytotox-
icity (Banerjee, 2012; Ohtsu et al., 2010). Interestingly, Opp
became progressively dispensable for PrfA activation while the
GshF dependence was maintained throughout the infection
time course (Figure 4A). Since L. monocytogenes is virtuallyCell Reports 26, 1815–1827, February 12, 2019 1823
Figure 7. Structure of PrfA in Complex with LL Dipeptide
(A) Ribbon representation of PrfA homodimer showing the binding sites of LL (top) and GSH (bottom) at the interdomain tunnel. Monomers A and B are colored in
blue and gray, respectively, and the ligands are in stick representation (with C atoms in salmon color). Specific features of the C-terminal DNA-binding domain are
indicated inmonomer A, including Tyr154 (aD) involved in PrfA’s GSH-mediated activation and LL-mediated inhibition. Critical movements in GSH-mediated PrfA
activation, which lead to the partial collapse of the tunnel and repositioning of HTH’s aE—prevented by LL binding—are indicated in the bottom panel. Monomer B
shows the interdomain tunnel cavity as transparent orange surface.
(B) Key local features and amino acids forming direct hydrogen bonds (dashed lines) to the LL peptide in monomer A. See Figures S7D–S7F for further details of
LL-PrfA interactions.
(C) Superposition based on residues 2–138 of monomer A of PrfAWT (PDB code 2BEO, yellow), PrfA:LL (PDB code 6HCK, this work, crimson red) and PrfA:GSH
(PDB code 5LRR, lilac). Residues 121138 and 170195 (HTH-motif) are shown as ribbon diagram. Binding of GSH induces large structural changes in the
C-terminal DNA-binding domain of PrfA (residues 139227), including the formation of water-mediated hydrogen bonds between GSH and Ser177 (dotted lines,
water molecules in the PrfA-GSH complex are shown as red spheres). The side chain of Leu1 is sterically hindering the movement of Tyr154 necessary for PrfA
activation (red arrow). The distances between Leu1 (crimson) and Tyr154 (lilac) in the superimposed structures are less than 1 A˚.
See also Figure S7.auxotrophic to Cys (Tsai and Hodgson, 2003) (Figure 2D, right),
de novo bacterial synthesis of GSH obviously depends on an
external Cys source. Prolonged infection may lead to gradual
depletion of Opp-transported oligopeptides, resulting in critical
alteration of the Cys-providing (inducing)/non-Cys-containing
(inhibitory) peptide balance, only necessitating the input of
relatively minor amounts of free Cys for PrfA induction. Alterna-
tively, other listerial transporters (e.g., dipeptide transporters)
may take over the role of Opp in Cys-peptide import, or addi-1824 Cell Reports 26, 1815–1827, February 12, 2019tional (co)factors may contribute to PrfA activation under Cys/
Cys-peptide (GSH)-limiting conditions.
The reported data support a model in which PrfA activity is
antagonistically modulated by activating and inhibitory nutri-
tional peptides, with the Opp transport system as a key player
upstream of GshF in the PrfA regulation hierarchy (Figure S8).
This model reconciles the essentiality of GshF/GSH for PrfA acti-
vation (Reniere et al., 2015; Portman et al., 2017) with most
known features of listerial virulence regulation, including the
contrasting PrfA phenotypes in complex (Ripio et al., 1996,
1997b) versus chemically defined media (Bohne et al., 1994) or
the intriguing ‘‘charcoal’’ effect (Ripio et al., 1996; Ermolaeva
et al., 2004). The model provides a unifying framework to inter-
pret how the facultative pathogen L. monocytogenes senses
niche transitions and adjusts virulence gene expression
accordingly.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacteria, plasmids, culture conditions, chemicals
The strains and plasmids used in this study are shown in Table S2. Listeria were routinely grown in porcine BHI (BD-Difco) and Es-
cherichia coli in Luria-Bertani (LB) media, with 1% agar for solid cultures. For adsorbent-treated BHI agar, 1% (w/v) Amberlite XAD4
resin (Sigma-Aldrich) or 0.5% (w/v) activated charcoal powder (Merck) was added to the medium prior to autoclaving. For fluid Am-
berlite XAD4-treated BHI cultures (BHI-Amb), the resin was aseptically removed after autoclaving to avoid interference with optical
density (OD) readings. Chemically defined CDM is amodification of the improvedminimal medium (IMM) of Phan-Thanh andGormon
(1997), with the following composition: 6.56 g/L KH2OP4, 30.96 g/L NaHPO4 7H2O, 0.41 g/L MgSO4, 88 mg/L ferric citrate, 0.1 g/L
each of the (L-) amino acids leucine, isoleucine, valine, methionine, arginine, cysteine, histidine and tryptophan, 0.6 g/L L-glutamine,
2.5 mg/L adenine, 0.5 mg/L biotin, 5 mg/L riboflavin, 1 mg/L each of thiamine, pyridoxal, para-aminobenzoic acid, calcium pan-
thothenate and nicotinamide, 5 mg/L thioctic acid and 4.5 g/L glucose. CDM was used freshly prepared from filter-sterilized stock
solutions stored at 4C (except cysteine, glutamine, biotin and ferric citrate solutions, kept at –20C; and phosphates, MgSO4
and glucose, at room temperature). Antibiotic supplements (mg/mL) were as follows (lower values for Listeria, others for E. coli
or both): erythromycin 5 or 250, chloramphenicol 7.5 or 20, spectinomycin 100, carbenicillin 100. All incubations were carried
out at 37C, with 180 rpm orbital shaking for fluid cultures, unless stated otherwise. GSH was kept in reduced state with 2 mM
Tris[2-carboxyethyl]phosphine hydrochloride (TCEP) in the stock solution. Chemicals and oligonucleotides were from Sigma-Aldrich
unless otherwise indicated.
Cell culture
Low passage J774A.1 cells, a female murine macrophage cell line, were maintained in a humidified incubator at 37C and 5%CO2 in
DMEM (GIBCO) without antibiotics supplemented with 10% FBS (GIBCO).
Mice
Experiments were covered by a Project License granted by the UK Home Office under the 1986 Animals (Scientific Procedures). The
Roslin Institute Ethical Review Committee approved this license and the experiments (Project A933). Female, six weeks old BALB/c
mice were purchased from Charles River. Mice were group-housed in Level 2 SPF barrier facility at the Roslin Institute, University of
Edinburgh (UK), and feed a regular chow diet ad libitum.
METHOD DETAILS
General DNA techniques
PCR was performed with GoTaq DNA polymerase (Promega) for general purposes or high-fidelity PfuUltra II Fusion HS (Agilent) for
gene constructs or sequence validation. Plasmid and PCR DNA was purified with QIAprep Plasmid Mini kit and QIAquick PCR pu-
rification kit, respectively (QIAGEN). Plasmids were introduced into L. monocytogenes by electroporation using a Gene Pulser Xcell
apparatus (Bio-Rad) and into E. coli by chemical transformation. Restriction enzymes were used according to the manufacturer’s
instructions (New England Biolabs). DNA sequences were determined using the Sanger method at Source BioScience
(Livingston, UK).
Transposon library and screening
A random insertion library was constructed in P14-Phly-lux (wild-type L. monocytogenes P14 complemented with a PrfA-regulated
bioluminescent gene reporter in the integrative plasmid pPL2lux-PhlyA (Bron et al., 2006)) by himar1 transposon mutagenesis using
plasmid pJZ037 (Zemansky et al., 2009). For direct isolation of transposon mutants unable to express PrfA-dependent genes in BHI-
Amb, we used the PrfA-regulated virulence gene hpt as a ‘‘natural’’ negative selection marker. hpt encodes a sugar phosphate
(organophosphate) permease that promotes rapid bacterial replication in the host cytosol but which also transports fosfomycin,
rendering L. monocytogenes susceptible to the antibiotic when PrfA is induced (Scortti et al., 2006). Selection was performed in
150 mg/ml fosfomycin (MIC for P14 in BHIA-Amb z12-32 mg/ml) and resistant clones subjected to phenotypic screening and
PCR analysis to exclude Tn insertions in hpt or prfA. The prfA genewas also sequenced in all PrfA– mutants with correct PCR patterns
for presence of non-synonymous point mutations. Transposition mapping was by colony PCR using relevant oligonucleotides (Table
S3).
Genetic constructs
Oligonucleotides used to generate PCR fragments for cloning contained suitable restriction site extensions at their 50 end (Table S3).
Complementations were carried out using the pAT29 bifunctional vector with spectinomycin selection (Trieu-Cuot et al., 1990),
compatible with the erythromycin resistance marker of the transposable element. For complementation of oppF::Tn, the oppF
gene with its native promoter (PoppF, Figure 1A) was PCR-amplified from strain P14 with oligonucleotide primers 21 and 22 and in-
serted into pAT29’s multicloning site (MCS) (plasmid pAToppFPoppF). oppF was also placed under the control of the oppA-F operon
promoter (Popp) (Figure 1A) by inserting the corresponding region, amplified using primers 19 and 20, in the adequate orientation intoCell Reports 26, 1815–1827.e1–e5, February 12, 2019 e2
pAToppFPoppF (plasmid pAToppFPopp). gshFwas overexpressed from pAT29 by inserting into the vector’s MCS a PCR segment con-
taining the strong gram-positive promoter Pd from the streptococcal pSM19035 plasmid partitioning gene d (de la Hoz et al., 2000),
flanked by SalI and BanHI restriction sites, followed by the gshF gene amplified from P14 with primers 25 and 26 (plasmid
pATgshFPd). For insertional mutagenesis of oppF and oppD, internal PCR fragments to each gene, amplified from P14 with primer
pairs 35-36 and 37-38, respectively, were inserted into the bifunctional thermosensitive vector pAULA (Scha¨ferkordt and Chakra-
borty, 1995), giving the recombinogenic plasmids pAUoppF and pAUoppD. The same strategy was followed to disable plcA-prfA
readthrough transcription by insertional disruption of the plcA gene (strain P14prfAmc; primers 39 and 40 were used to generate
the internal plcA fragment). The in-frame DoppDF and DgshF deletion mutants were constructed by allelic exchange. For
DoppDF, primer pairs 31-32 and 33-34 were used to amplify 401-bp and 575-bp fragments corresponding to the first 60 bp of
oppD and its upstream region and the last 33 bp of oppF and its downstream region, respectively. For DgshF, primer pairs 27-28
and 29-30 were used to amplify 882-bp and 987-bp fragments corresponding to the first 60 bp of gshF and upstream region and
the last 80 bp of gshF and its downstream region, respectively. The amplicons were purified, digested with the appropriate restriction
enzymes and inserted into pAULA. After electroporation into L. monocytogenes, single and double crossover recombinants were
selected by marker selection and confirmed by PCR mapping and DNA sequencing.
Growth curves and gene expression analysis
PrfA-dependent gene expression was quantitatively analyzed throughout the L. monocytogenes growth curve using a chromoso-
mally integrated luxABCDE operon under the control of the PrfA-regulated hly promoter (Bron et al., 2006). Overnight bacterial cul-
tures werewashed, resuspended in PBS and used to inoculate freshmedium to an initial OD at 600 nm (OD600)z0.02-0.05. Triplicate
200-ml aliquots were transferred to opaque 96-well plates with clear bottom (ThermoScientific) andOD600 and luminescence readings
taken every 30 min during incubation in an automated microplate reader (FLUOstar Omega, BMG Labtech). Bioluminescence values
were normalized to growth at each time point. RT-qPCR transcription analysis was performed on total RNA samples extracted from
mid-exponential L. monocytogenes cultures (OD600z0.2-0.3 for BHImedia) using RNeasymini kit (QIAGEN) as previously described
(Deshayes et al., 2012). The number of transcripts was calculated by interpolation of threshold cycle (CT) values of cDNA amplifica-
tions in a standard regression curve generated from samples of known DNA concentration. Expession data were normalized by
dividing the number of transcripts of the test gene by the geometric mean of the number of transcripts of the reference housekeeping
genes rpoB and ldh (Deshayes et al., 2012). See Table S3 for oligonucleotides used.
Characterizaton of PrfA and Opp phenotypes
The PrfA phenotype was examined using three PrfA-regulated genes as natural reporters: hly encoding the hemolysin listeriolysin
O (LLO), plcB encoding the phospholipase C/lecithinase PlcB, and hpt encoding the sugar phosphate Hpt permease (Scortti
et al., 2006). Hemolytic activity was quantified in U-shaped 96-well microtiter plates by mixing 100 ml two-fold serially diluted culture
supernatant (OD600z0.2) in 1%dithiothreitol PBSwith 100 ml of an 1%suspension of washed sheep erythrocytes in PBS (Ripio et al.,
1996). Titers were the reciprocal of the highest dilution whereR 50% of hemolysis was visually observed after 90 min incubation at
37C. PlcB activity was determined by observing the width of the white fatty acid precipitate around the colonies in BHI-basedmedia
containing 10% egg yolk suspension (prepared by dispersing one egg yolk in 100 mL of sterile saline) (Ripio et al., 1996). Hpt activity
was determined using a sugar acidification test in phenol red base broth (Oxoid) supplemented with 10 mM glucose-1-phosphate
(Ripio et al., 1997a). See Figures S1A–S1C. Opp (oligopeptide transport) function was tested by measuring the susceptibility to
the toxic tripeptide bialaphos (Borezee et al., 2000). Tests were performed using 6-mm antibiotic assay discs (Whatman) impreg-
nated with 30 mg bialaphos (Cayman Chemical) on CDM plates seeded with 120 ml bacterial culture (OD600z0.2), or by monitoring
bacterial growth in CDM supplemented with 30 mg/mL bialaphos (see Figure S1E).
Western immunoblotting
L. monocytogenes bacterial pellets from 10-mL broth cultures collected at OD600z0.2-0.3 were washed, resuspended in 500 mL 100
mM Tris, 150 mM NaCl containing Protease Inhibitors Cocktail (Roche) and lysed in Lysin Matrix B tubes with silica beads using a
FastPrep homogenizer (MP biomedicals). After centrifuging to remove beads and cell debris, supernatants were collected and
the protein concentration determined using a Bradford assay (Sigma-Aldrich). Proteins in bacterial lysates were separated by
SDS-PAGE using Bis-Tris Nupage precast gels ran with MOPS buffer (Thermo Fisher), transferred to PVDF membranes, and PrfA
protein detected using an anti-PrfA rabbit polyclonal antibody (1:50,000) and anti-rabbit HRP-conjugated secondary antibody
(Cell signaling, 1:5,000). Membranes were developed using G-Box chemiluminescent imaging (Syngene), scanned and densitometri-
cally analyzed with Image Studio Lite (LI-COR) using anz80-kDa non-specific band as an internal control for normalization.
GSH determinations
Total GSH (GSHt = GSH [reduced] + GSSG [oxidized]) was measured in exponentially growing L. monocytogenes cells using the
GSH assay kit from Abcam. Briefly, bacteria were disrupted by bead-beating as described above, lysates deproteinized using a
TCA-based commercial kit (Abcam), and fluorescence determined in an Omega plate reader (BMG).e3 Cell Reports 26, 1815–1827.e1–e5, February 12, 2019
Intracellular infection assays
Intracellular proliferation of L. monocytogeneswas analyzed in J774A.1murinemacrophages using a standard gentamicin protection
assay (Deshayes et al., 2012), with some modifications. Cell monolayers were infected at 10:1 multiplicity for 30 min, washed twice
with PBS to remove extracellular bacteria, and incubated in DMEM supplemented with 100 mg/ml gentamicin for 30 min (t = 0). In
some experiments, J774 cells were deprived of Cys for 4 h and then treated with 200 mM of the GSH-depleting drug L-buthio-
nine-(S,R)-sulfoximine (BSO) (Cayman) 1 h prior to and throughout infection. Intracellular bacterial numbers (IB) were normalized us-
ing an ‘‘Intracellular growth coefficient’’ (IGC) at each time point t = n respect to the internalized bacteria at t = 0 according to the
formula: IGC = (IBtn — IBt0) / IBt0 (Deshayes et al., 2012; Vasanthakrishnan et al., 2015). For intracellular competition assays, mono-
layers were infected with 1:1 mixes of the competing bacteria and their proportions determined at different time points by PrfA phe-
notyping on egg-yolk BHI agar (see Figure S1A). The competitive indexes (C.I.) were determined as specified below.
Mouse experiments
BALB/c mice were infected via the tail vein with 1.5 3 103 CFU of az1:1 mix of wild-type L. monocytogenes and isogenic DoppDF
derivative. After euthanasia at days 0, 3 and 5 after infection, livers and spleens were recovered, homogenized and corresponding
bacterial loads determined by plate counting (threemice per group per time point). At least 50 colonies per time point and animal were
randomly analyzed to determine the proportion of each bacterial strain by PCR, based on the size of the PCR product (primers
DoppDF 1 BamHI and DoppDF 2 SacI; Table S3). The competitive indexes were calculated using inferred log cfu values with the for-
mula C.I. = (test/reference log cfu ratio at t = n)/(test/reference log cfu ratio at t = 0).
PrfA purification and biophysical assays
Bacterial pellets of IPTG-induced cultures of E. coli BL21(pET28aprfAWT) (Deshayes et al., 2012; Table S2) were resuspended in lysis
buffer (50 mM Tris pH 7.5, 300mMNaCl, 20mM imidazole) and lysed with an EmulsiFlex homogenizer. After affinity chromatography
on a HiTrap HP nickel column in an AKTA system (GE Healthcare), PrfA-containing fractions were pooled together, loaded on a
HiTrap Heparin HP column and then on a Superdex 75 Gel Filtration column to remove nucleic acid and protein contaminants.
The buffer used for the gel filtration and storage was 50 mM Tris pH 7.5, 300 mM NaCl. Fluorescence-based thermal shift assays
were performed in a real-time PCR instrument (Bio-Rad) using 25 mL triplicate samples containing 10 mM recombinant PrfA, 5 3
SyprOrange (Invitrogen) and 1 mM synthetic peptide. Isothermal Titration Calorimetry (ITC) experiments were performed in a GE
MicroCal iTC200 system (GE Healthcare). PrfA was changed to 50 mM Tris pH 7.5, 500 mM NaCl buffer and 100 mM of PrfA protein
injected into the cell. After the baseline was established for 5-10 min, 2 mL of 250 mM peptide in the same buffer was injected every
60 s into PrfA. Data were analyzed with the inbuilt software of the ITC apparatus using a one-site model. The specific DNA-binding
activity of PrfA was measured by biolayer interferometry (BLI) with a Forte´Bio OctetRED 96 apparatus using a biotinylated double-
stranded oligonucleotide containing the PplcA/hly PrfA box (Table S3). BLI sensorgrams were determined by dipping streptavidin
sensors loaded with the target DNA into wells containing sample buffer (50mMTris-Cl pH 7.5 300mMNaCl, 0.05 Tween 20) to obtain
a baseline (60 s), then into wells containing increasing dilutions of PrfA-ligand mixes at 1:100 molar ratio in the same buffer to monitor
association (300 s), followed by a dissociation step (300 s). Forte´Bio data acquisition and analysis v9 software was used to determine
binding responses.
PrfA-LL co-crystallization, data collection and refinement
For crystallization studies, PrfA was recombinantly expressed in E. coli using the pET28a expression vector with a 6-His tag and To-
bacco etch virus (TEV) protease cleavage site. The construct encodes the full-length PrfAWT protein with two non-native N-terminal
residues (GA) on TEV cleavage. The cleavage product was purified by MonoS 5/5 ion-exchange (GE- Healthcare) with elution
at 250 mM NaCl in 10 mM Tris pH 7.5, 1 mM DTT, followed by a final size-exclusion chromatography step performed in a HiLoad
Superdex 75 16/60 column (GE Healthcare) equilibrated with 20 mM sodium phosphate pH 6.5, 200 mM NaCl. The peak fractions
containing PrfA were pooled and concentrated using a Centriprep-10 centrifugal concentrator (Millipore) to a final concentration of
3.5 mg/ml. Purified PrfA (> 95%) in complex with LL was crystallized by the hanging-drop vapor-diffusion method in VDX plates
(Hampton Research) at 18C. Before the crystallization setup, LL was added to the protein solution to a final molar protein-to-ligand
ratio of 1:5. Droplets of 4 mL of the protein-LL complex were mixed with 2 mL of reservoir solution consisting of 20% PEG 4000,
100 mM sodium citrate (pH 5.2) and 17% isopropanol. Crystals used for data collection were obtained after 48 h. Diffraction data
at 173C were collected at the ESRF (beamline ID23-2; l = 0.873 A˚). Diffraction images were processed with XDS (Kabsch,
1993) and scaled and merged using AIMLESS from the CCP4 software suite (Bailey, 1994). The structure was determined by molec-
ular replacement with the PHASER program from the PHENIX program suite (Adams et al., 2010) using the high resolution wild-type
PrfA structure determined in complex with the inhibitor KSK67 (PDB ID code 6EUT) (Kule´n et al., 2018) as the search model. The
atomic models were manually built using Coot (Emsley et al., 2010) and refined with PHENIX Refine (Adams et al., 2010). The quality
of the electron density map of the ligandwas significantly improved in POLDER omit map (Liebschner et al., 2017), and the ligandwas
modeled with LigandFit with a CC = 0.79 (Figures S7D–S7F) (Terwilliger et al., 2006, 2007). Data collection and refinement
statistics are shown in Table S1. Ramachandran outliers are < 0.2%. Figures were prepared with CCP4mg (McNicholas et al.,
2011) or PyMOL.Cell Reports 26, 1815–1827.e1–e5, February 12, 2019 e4
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using GraphPad Prism software. Data with single comparisons were analyzed using two-tailed
t test. Data with multiple comparisons were assessed using one-way or two-way ANOVA tests with the appropriate post hoc
comparisons, with only relevant comparisons noted on the figures. Figure legends include the exact number of replicates for
each experiment and the specific statistical analysis.
DATA AVAILABILITY
The atomic coordinates and structure factors for the PrfA-LL peptide complex have been deposited in the Protein Data Bank under
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